Last €45.82 EUR
Change Today +0.43 / 0.95%
Volume 0.0
JUD On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 2:16 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

st jude medical inc (JUD) Snapshot

Open
€45.78
Previous Close
€45.39
Day High
€45.82
Day Low
€45.77
52 Week High
03/6/14 - €49.93
52 Week Low
05/2/13 - €30.87
Market Cap
13.0B
Average Volume 10 Days
169.5
EPS TTM
--
Shares Outstanding
283.9M
EX-Date
03/27/14
P/E TM
--
Dividend
€1.09
Dividend Yield
1.69%
Current Stock Chart for ST JUDE MEDICAL INC (JUD)

st jude medical inc (JUD) Related Businessweek News

No Related Businessweek News Found

st jude medical inc (JUD) Details

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems that provide therapy to patients suffering from heart conditions, such as sudden cardiac arrest; and cardiac resynchronization therapy devices to treat patients suffering from heart failure. It also provides pacemakers for patients whose hearts beat too slowly or who suffer from other cardiac arrhythmias; leads to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment, which are used by physicians and healthcare professionals to program cardiac rhythm management devices and analyze device data to enhance patient management. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, vascular plugs, percutaneous catheter introducers, and diagnostic guidewires; and transcatheter aortic heart valves, heart valve repair and replacement products, and transcatheter structural heart defect devices. Further, it provides electrophysiology introducers and catheters, and ablation systems, as well as cardiac mapping, navigation, and recording systems for diagnosing and treating various irregular heart rhythms. Additionally, the company offers neurostimulation systems for chronic pain, such as rechargeable and primary cell implantable pulse generators. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in Saint Paul, Minnesota.

16,000 Employees
Last Reported Date: 02/26/14
Founded in 1976

st jude medical inc (JUD) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.0M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $430.0K
Chief Operating Officer
Total Annual Compensation: $730.0K
President of International Division
Total Annual Compensation: $752.4K
Executive Vice President
Total Annual Compensation: $730.0K
Compensation as of Fiscal Year 2013.

st jude medical inc (JUD) Key Developments

St. Jude Medical Inc. Announces the Approval of its Protégé(TM) IPG from the U.S. Food and Drug Administration

St. Jude Medical Inc. announced the approval of its Protégé(TM) IPG from the U.S. Food and Drug Administration (FDA). Protégé is the first and only neurostimulation system that allows spinal cord stimulation (SCS) technology upgrades as they are approved to be made via software updates. Chronic pain sufferers implanted with this new device can access innovative therapies, stimulation modes, diagnostics or other features once approved through future software upgrades -- without the need to surgically replace their medical device. Chronic pain affects 100 million Americans, more than heart disease, cancer and diabetes combined. The debilitating disease is cause for 40 % of work absences due to back pain, second only to the common cold (50%), and costs the nation more than $635 billion each year in medical treatment and lost productivity. SCS is a proven therapy that has been used to help manage chronic pain and improve patients' quality of life.

St. Jude Medical Inc., Q1 2014 Earnings Call, Apr 16, 2014

St. Jude Medical Inc., Q1 2014 Earnings Call, Apr 16, 2014

St. Jude Medical Inc. to Report Q1, 2014 Results on Apr 16, 2014

St. Jude Medical Inc. announced that they will report Q1, 2014 results at 7:30 AM, US Eastern Standard Time on Apr 16, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JUD:GR €45.82 EUR +0.43

JUD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $13.48 USD +0.125
Coloplast A/S kr418.20 DKK +6.00
Smith & Nephew PLC 860.50 GBp -11.00
Terumo Corp ¥2,119 JPY +51.00
Zimmer Holdings Inc $91.46 USD -1.16
View Industry Companies
 

Industry Analysis

JUD

Industry Average

Valuation JUD Industry Range
Price/Earnings 25.4x
Price/Sales 3.4x
Price/Book 4.3x
Price/Cash Flow 24.8x
TEV/Sales 2.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ST JUDE MEDICAL INC, please visit www.sjm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.